Pyrroloquinoline quinone (PQQ), also known as methoxatin, is a tricyclic orthoquinone that functions as a cofactor in bacterial metabolic enzymes and is found in trace amounts in many foods (fermented soybeans/natto, green tea, kiwi fruit, human breast milk, and many plant foods). It has attracted significant scientific interest primarily for its role in mitochondrial biogenesis — the process by which cells generate new mitochondria — and its capacity as an exceptionally potent redox cycling cofactor, capable of catalyzing thousands of redox cycles without degradation.
PQQ was proposed in 2003 to be an essential nutrient for mammals — findings suggesting that mice deprived of PQQ showed impaired growth and reproductive capacity. While subsequent research has not definitively classified PQQ as a dietary essential nutrient in the classical sense (deficiency does not produce a defined deficiency disease), the functional significance of dietary PQQ intake for mitochondrial health and oxidative stress management is increasingly supported by both animal and human studies.
The central mechanism relevant to cognitive health is PQQ's activation of multiple transcription factors — particularly CREB (cAMP response element-binding protein) and PGC-1α — that drive mitochondrial biogenesis. More mitochondria per neuron means greater ATP production capacity, enhanced resilience to energy deprivation, and reduced susceptibility to neurodegenerative processes. PQQ also functions as a powerful free radical scavenger, protecting mitochondrial DNA from oxidative damage.
Human clinical trials with PQQ are limited but encouraging: a 2012 Japanese double-blind study found that PQQ supplementation (20mg/day) improved performance on cognitive tests in middle-aged adults, particularly in attention, memory, and processing speed. PQQ is increasingly combined with CoQ10 (which shares mitochondria-related mechanisms but operates differently) in commercial formulations, with some evidence of synergistic effects on mitochondrial function.